Gavin MacBeath
Chief Executive Officer chez TSCAN THERAPEUTICS, INC.
Fortune : 395 150 $ au 31/03/2024
Profil
Gavin MacBeath was the founder of Merrimack Pharmaceuticals, Inc. (founded in 1993) where he held the title of Senior Director & Head-Translational Research from 2011 to 2012.
He is currently the Chief Executive Officer & Director at TScan Therapeutics, Inc. since 2018.
Previously, he was the Chief Scientific Officer at Abpro Corp.
from 2017 to 2018 and an Associate Professor at Harvard University from 2002 to 2010.
Dr. MacBeath obtained his doctorate degree from The Scripps Research Institute in 1997 and his undergraduate degree from the University of Manitoba in 1991.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TSCAN THERAPEUTICS, INC.
0,11% | 13/06/2023 | 49 767 ( 0,11% ) | 395 150 $ | 31/03/2024 |
Postes actifs de Gavin MacBeath
| Sociétés | Poste | Début |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Chief Executive Officer | 28/03/2023 |
Anciens postes connus de Gavin MacBeath
| Sociétés | Poste | Fin |
|---|---|---|
| ABPRO CORPORATION | Chief Tech/Sci/R&D Officer | 01/07/2018 |
| MERRIMACK PHARMACEUTICALS, INC. | Founder | 01/09/2017 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/06/2010 |
Formation de Gavin MacBeath
| The Scripps Research Institute | Doctorate Degree |
| University of Manitoba | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
